Company intelligence / Profile preview

Great Health Companion Group

China

Ownership: Private
Development stage: Other

Overview

Great Health Companion Group (好医友) operates a digital healthcare platform providing online medical consultation and second-opinion services, particularly connecting patients in China with overseas (notably US) experts; it is a service/health IT provider rather than a drug-development company.[7][8]

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Kinarus Therapeutics (engagement to explore China partnerships and funding options for Phase 2 trials of KIN001).[8]

Beyond the preview

Go deeper on Great Health Companion Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Great Health Companion Group.

Explore the full profile